📣 VC round data is live. Check it out!

Bioextrax Valuation Multiples

Discover revenue and EBITDA valuation multiples for Bioextrax and similar public comparables like EcoUp, De.mem, Close The Loop, GEL and more.

Bioextrax Overview

About Bioextrax

Bioextrax AB is engaged in the development and production of bio-plastics granules, organic hydrolyzed protein, and keratin fibers.


Founded

2014

HQ

Sweden

Employees

N/A

Financials (LTM)

Revenue: $125K
EBITDA: ($2M)

EV

$13M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Bioextrax Financials

Bioextrax reported last 12-month revenue of $125K and negative EBITDA of ($2M).

In the same LTM period, Bioextrax generated $7K in gross profit, ($2M) in EBITDA losses, and had net loss of ($2M).

Revenue (LTM)


Bioextrax P&L

In the most recent fiscal year, Bioextrax reported revenue of $83K and EBITDA of ($2M).

Bioextrax is unprofitable as of last fiscal year, with gross margin of (64%), EBITDA margin of (2133%), and net margin of (2278%).

See analyst estimates for Bioextrax
LTMLast FY202320242025202620272028
Revenue$125K$83K$221K$55K$81K
Gross Profit$7K($54K)$77K($98K)($54K)
Gross Margin5%(64%)35%(178%)(66%)
EBITDA($2M)($2M)($2M)($2M)($2M)
EBITDA Margin(1432%)(2133%)(1004%)(3141%)(2190%)
EBIT Margin(1528%)(2296%)(1051%)(3406%)(2357%)
Net Profit($2M)($2M)($2M)($2M)($2M)
Net Margin(1521%)(2278%)(1046%)(3367%)(2339%)

Financial data powered by Morningstar, Inc.

Bioextrax Stock Performance

Bioextrax has current market cap of $13M, and enterprise value of $13M.

Market Cap Evolution


Bioextrax's stock price is $0.28.

Bioextrax share price decreased by 3.4% in the last 30 days, and by 10.2% in the last year.

Bioextrax has an EPS (earnings per share) of $-0.04.

See more trading valuation data for Bioextrax
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$13M$13M-0.9%-3.4%-13.8%-10.2%$-0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Bioextrax Valuation Multiples

Bioextrax trades at 104.5x EV/Revenue multiple, and (7.3x) EV/EBITDA.

See NTM and 2027E valuation multiples for Bioextrax

EV / Revenue (LTM)


Bioextrax Financial Valuation Multiples

As of May 26, 2026, Bioextrax has market cap of $13M and EV of $13M.

Bioextrax has a P/E ratio of (7.1x).

LTMLast FY202320242025202620272028
EV/Revenue104.5x156.1x59.0x235.5x160.2x
EV/EBITDA(7.3x)(7.3x)(5.9x)(7.5x)(7.3x)
EV/EBIT(6.8x)(6.8x)(5.6x)(6.9x)(6.8x)
EV/Gross Profitn/m(242.0x)168.9x(132.5x)(242.0x)
P/E(7.1x)(7.1x)(5.8x)(7.2x)(7.1x)
EV/FCF—(4.6x)(5.0x)(6.4x)(4.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Bioextrax Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Bioextrax Margins & Growth Rates

Bioextrax grew revenue by 123% but EBITDA decreased by 5% in the last fiscal year.

In the most recent fiscal year, Bioextrax reported gross margin of (64%), EBITDA margin of (2133%), and net margin of (2278%).

See estimated margins and future growth rates for Bioextrax

Bioextrax Margins

Last FY202420252026202720282029
Gross Margin(64%)(178%)(66%)54%
EBITDA Margin(2133%)(3141%)(2190%)(911%)
EBIT Margin(2296%)(3406%)(2357%)(972%)
Net Margin(2278%)(3367%)(2339%)(972%)
FCF Margin(3371%)(3688%)(3461%)—

Bioextrax Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth123%(75%)47%129%
Gross Profit Growth(286%)(227%)(45%)(286%)
EBITDA Growth(5%)(22%)2%(5%)
EBIT Growth(5%)(19%)2%(5%)
Net Profit Growth(5%)(19%)2%(5%)
FCF Growth—(22%)38%—

Data powered by FactSet, Inc. and Morningstar, Inc.

Bioextrax Operational KPIs

Bioextrax's Rule of 40 is (782%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Bioextrax's Rule of X is (588%) (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Bioextrax
LTMLast FY202320242025202620272028
Rule of 40(1256%)(782%)———
Bessemer Rule of X(993%)(588%)———
Opex to Revenue—2231%1085%3228%2290%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Bioextrax Competitors

Bioextrax competitors include EcoUp, De.mem, Close The Loop, GEL, Ocean GeoLoop, PowerHouse Energy Group, Axolot Solutions Holding, Pryme, Saxlund Group and Bawat Water.

Most Bioextrax public comparables operate across Waste & Environmental Services.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
EcoUp0.5x0.6x13.4x16.1x
De.mem0.6x0.5x11.3x7.4x
Close The Loop0.5x0.6x8.3x—
GEL————
Ocean GeoLoop0.3x—(2.4x)—
PowerHouse Energy Group21.8x9.3x(2.3x)(3.3x)
Axolot Solutions Holding7.4x—(16.1x)—
Pryme15.3x—(1.6x)—

This data is available for Pro users. Sign up to see all Bioextrax competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Bioextrax

When was Bioextrax founded?Bioextrax was founded in 2014.
Where is Bioextrax headquartered?Bioextrax is headquartered in Sweden.
Is Bioextrax publicly listed?Yes, Bioextrax is a public company listed on Nasdaq Stockholm.
What is the stock symbol of Bioextrax?Bioextrax trades under BIOEX ticker.
When did Bioextrax go public?Bioextrax went public in 2022.
Who are competitors of Bioextrax?Bioextrax main competitors include EcoUp, De.mem, Close The Loop, GEL, Ocean GeoLoop, PowerHouse Energy Group, Axolot Solutions Holding, Pryme, Saxlund Group, Bawat Water.
What is the current market cap of Bioextrax?Bioextrax's current market cap is $13M.
What is the current revenue of Bioextrax?Bioextrax's last 12 months revenue is $125K.
What is the current revenue growth of Bioextrax?Bioextrax revenue growth (NTM/LTM) is 176%.
What is the current EV/Revenue multiple of Bioextrax?Current revenue multiple of Bioextrax is 104.5x.
Is Bioextrax profitable?No, Bioextrax is not profitable.
What is the current EBITDA of Bioextrax?Bioextrax has negative EBITDA and is not profitable.
What is Bioextrax's EBITDA margin?Bioextrax's last 12 months EBITDA margin is (1432%).
What is the current EV/EBITDA multiple of Bioextrax?Current EBITDA multiple of Bioextrax is (7.3x).
How many companies Bioextrax has acquired to date?Bioextrax hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Bioextrax has invested to date?Bioextrax hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Bioextrax

Lists including Bioextrax

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial